We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.55B
AUM Growth
-$449M
Cap. Flow
-$417M
Cap. Flow %
-27.01%
Top 10 Hldgs %
47.59%
Holding
143
New
19
Increased
20
Reduced
61
Closed
22

Top Buys

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$12.3M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$9.39M
3
COST icon
Costco
COST
+$7.88M
4
IDYA icon
IDEAYA Biosciences
IDYA
+$3.29M
5
CDXS icon
Codexis
CDXS
+$3.09M

Top Sells

Rank Stock Value
1
SNDX icon
Syndax Pharmaceuticals
SNDX
+$28.9M
2
LNW
Light & Wonder
LNW
+$20.6M
3
SMLR
Semler Scientific
SMLR
+$10.3M
4
BBQ
BBQ Holdings, Inc. Common Stock
BBQ
+$9.88M
5
IIII
INSU Acquisition Corp. III Class A Common Stock
IIII
+$9.65M

Sector Composition

Rank Sector Weight
1 Healthcare 28.65%
2 Consumer Discretionary 12.74%
3 Industrials 6.25%
4 Communication Services 4.08%
5 Financials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRY icon
51
ARS Pharmaceuticals
SPRY
$588M
$6.6M 0.43%
1,249,863
-136,275
-10% -$672K
PRDO icon
52
PUT
Perdoceo Education
PRDO
$1.99B
$5.15M 0.33%
500,000
– –
ONTF
53
DELISTED
ON24
ONTF
$4.74M 0.31%
538,906
-31,497
-6% -$302K
APTO
54
DELISTED
Aptose Biosciences, Inc.
APTO
$4.1M 0.27%
15,308
-765
-5% -$264K
VTYX
55
DELISTED
Ventyx Biosciences
VTYX
$4.07M 0.26%
+116,633
New +$2.58M
RDNW
56
RideNow Group
RDNW
$243M
$4.01M 0.26%
236,975
+36,975
+18% +$746K
SSKN
57
DELISTED
Strata Skin Sciences
SSKN
$3.83M 0.25%
439,369
-18,212
-4% -$185K
IDYA icon
58
IDEAYA Biosciences
IDYA
$3.53B
$3.78M 0.24%
+253,480
New +$3.29M
TSHA icon
59
Taysha Gene Therapies
TSHA
$1.84B
$3.25M 0.21%
1,610,822
-32,616
-2% -$118K
PWP icon
60
Perella Weinberg Partners
PWP
$1.3B
$3.2M 0.21%
505,293
+2,617
+0.5% +$18.6K
RILY icon
61
BRC Group Holdings
RILY
$296M
$3.04M 0.2%
68,296
-8,787
-11% -$439K
TELA icon
62
TELA Bio
TELA
$36.5M
$2.97M 0.19%
+349,002
New +$2.89M
CDTX
63
DELISTED
Cidara Therapeutics
CDTX
$2.92M 0.19%
227,960
-12,995
-5% -$179K
ARYD
64
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.83M 0.18%
285,730
-37,199
-12% -$367K
SMLR
65
DELISTED
Semler Scientific
SMLR
$2.72M 0.18%
72,397
-274,209
-79% -$10.3M
IMTXW
66
DELISTED
Immatics N.V. Warrants
IMTXW
$2.68M 0.17%
987,432
-48,181
-5% -$151K
BVS icon
67
Bioventus
BVS
$1.16B
$2.65M 0.17%
+378,839
New +$2.97M
CRIS icon
68
Curis
CRIS
$4.79M
$2.43M 0.16%
8,551
-519
-6% -$209K
TCDA
69
DELISTED
Tricida, Inc. Common Stock
TCDA
$2.41M 0.16%
+229,610
New +$2.51M
SRL icon
70
Scully Royalty
SRL
$89.1M
$2.36M 0.15%
318,493
-452,703
-59% -$3.71M
PAYO icon
71
Payoneer
PAYO
$2.41B
$2.33M 0.15%
385,366
– –
RZLT icon
72
Rezolute
RZLT
$449M
$1.97M 0.13%
+718,736
New +$2.08M
AAN
73
DELISTED
The Aaron's Company Inc
AAN
$1.96M 0.13%
+201,467
New +$2.69M
SYRE icon
74
Spyre Therapeutics
SYRE
$8.87B
$1.95M 0.13%
148,431
-6,661
-4% -$82.3K
AVTX icon
75
Avalo Therapeutics
AVTX
$1.01B
$1.82M 0.12%
2,283
-47
-2% -$51K
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Nantahala Capital Management held 143 positions worth $1.55B, down 23% from $1.99B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Nantahala Capital Management withdrew a net $417M in Q3 2022, closing 22 positions and reducing 61 holdings. Its most notable exit was BBQ Holdings, Inc. Common Stock, an estimated $9.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in IDEAYA Biosciences worth $3.78M.

  • Nantahala Capital Management's largest Q3 2022 buy was IDEAYA Biosciences: 253,480 shares worth $3.78M.
  • Nantahala Capital Management added most to Pathward Financial in Q3 2022, an estimated $12.3M increase.
  • Nantahala Capital Management's biggest Q3 2022 reduction was Syndax Pharmaceuticals, cutting an estimated $28.9M.
  • Nantahala Capital Management fully exited BBQ Holdings, Inc. Common Stock in Q3 2022, selling an estimated $9.88M.
  • Nantahala Capital Management's ten largest holdings make up 48% of its $1.55B portfolio in Q3 2022.
  • Nantahala Capital Management opened 19 new positions and closed 22 in Q3 2022.
  • Nantahala Capital Management's portfolio value fell 23% quarter-over-quarter to $1.55B.

Based on Nantahala Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.